Maculopathies: A Systematic Literature Review on Pathophysiology, Public Health, and Treatment
Author Information
Author(s): Muacevic Alexander, Adler John R, Pantelidou Maria E, Sunnucks David, Pantelidis Elias P
Conclusion
Maculopathies are diverse diseases that cause severe central vision loss, and while current treatments are limited, ongoing research into gene therapy and stem cell treatments offers hope for future improvements.
Supporting Evidence
- Age-related macular degeneration (AMD) is the leading cause of visual loss in older populations.
- Diabetic maculopathy is the most prevalent cause of visual impairment in those with diabetic retinopathy.
- Stem cell research shows promise for future therapies that could slow or prevent progressive visual loss.
Takeaway
Maculopathies are eye diseases that can make it hard to see clearly, especially in the center of your vision. Scientists are working on new treatments to help people with these conditions.
Methodology
This systematic review followed PRISMA guidelines and included literature searches from multiple databases.
Potential Biases
The quality assessment was performed by independent reviewers to reduce publication bias.
Limitations
The review may be limited by the availability of peer-reviewed articles and the focus on English language documents.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website